BP000083-C005: Recombinant Human IFNα 2b Protein
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV- WISH cells was found to be greater than 1.0 x 108 IU/ mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000083-C007: Recombinant Human IFNα 2b Pegylated
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be 1.0 x 106 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000083-CYT-034: Recombinant Human IFNα 2b 20kd-Pegylated
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be 1,000,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000083-CYT-205: Recombinant Human IFNα 2b Protein
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using bovine kidney MDBK cells was found to be 260,000,000 IU/ mg.
Purity: > 98% by SDS-PAGE and RP-HPLC. .BP000083-CYT-460: Recombinant Human IFNα 2b Protein, Yeast
Source: Saccharomyces cerevisiae-derived.
The specific activity as determined in a viral resistance assay was found to be no less than 300,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000083-GD25: Recombinant Human IFNα 2b Protein
Source: E. coli-derived.
The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000083-GD26: Recombinant Human IFNα 2b Pegylated
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^6 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).